220 related articles for article (PubMed ID: 15019477)
1. Characterisation of major peptides in 'jack jumper' ant venom by mass spectrometry.
Davies NW; Wiese MD; Brown SG
Toxicon; 2004 Feb; 43(2):173-83. PubMed ID: 15019477
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of Myrmecia pilosula (jack jumper) ant venom.
Wiese MD; Chataway TK; Davies NW; Milne RW; Brown SG; Gai WP; Heddle RJ
Toxicon; 2006 Feb; 47(2):208-17. PubMed ID: 16376960
[TBL] [Abstract][Full Text] [Related]
3. Myrmecia pilosula (Jack Jumper) ant venom: identification of allergens and revised nomenclature.
Wiese MD; Brown SG; Chataway TK; Davies NW; Milne RW; Aulfrey SJ; Heddle RJ
Allergy; 2007 Apr; 62(4):437-43. PubMed ID: 17362256
[TBL] [Abstract][Full Text] [Related]
4. Myrmecia pilosula (Jack Jumper) ant venom: validation of a procedure to standardise an allergy vaccine.
Wiese MD; Milne RW; Davies NW; Chataway TK; Brown SG; Heddle RJ
J Pharm Biomed Anal; 2008 Jan; 46(1):58-65. PubMed ID: 17933477
[TBL] [Abstract][Full Text] [Related]
5. Pilosulins: a review of the structure and mode of action of venom peptides from an Australian ant Myrmecia pilosula.
Wanandy T; Gueven N; Davies NW; Brown SG; Wiese MD
Toxicon; 2015 May; 98():54-61. PubMed ID: 25725257
[TBL] [Abstract][Full Text] [Related]
6. Pilosulin 5, a novel histamine-releasing peptide of the Australian ant, Myrmecia pilosula (Jack Jumper Ant).
Inagaki H; Akagi M; Imai HT; Taylor RW; Wiese MD; Davies NW; Kubo T
Arch Biochem Biophys; 2008 Sep; 477(2):411-6. PubMed ID: 18544336
[TBL] [Abstract][Full Text] [Related]
7. Stability of Myrmecia pilosula (Jack Jumper) Ant venom for use in immunotherapy.
Wiese MD; Davies NW; Chataway TK; Milne RW; Brown SG; Heddle RJ
J Pharm Biomed Anal; 2011 Jan; 54(2):303-10. PubMed ID: 20869831
[TBL] [Abstract][Full Text] [Related]
8. Towards complete identification of allergens in Jack Jumper (Myrmecia pilosula) ant venom and their clinical relevance: An immunoproteomic approach.
Wanandy T; Wilson R; Gell D; Rose HE; Gueven N; Davies NW; Brown SGA; Wiese MD
Clin Exp Allergy; 2018 Sep; 48(9):1222-1234. PubMed ID: 29975807
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and biological characterization of novel antimicrobial peptides, pilosulin 3 and pilosulin 4, from a species of the Australian ant genus Myrmecia.
Inagaki H; Akagi M; Imai HT; Taylor RW; Kubo T
Arch Biochem Biophys; 2004 Aug; 428(2):170-8. PubMed ID: 15246874
[TBL] [Abstract][Full Text] [Related]
10. A biochemical characterization of the major peptides from the Venom of the giant Neotropical hunting ant Dinoponera australis.
Johnson SR; Copello JA; Evans MS; Suarez AV
Toxicon; 2010 Apr; 55(4):702-10. PubMed ID: 19879289
[TBL] [Abstract][Full Text] [Related]
11. Identification of an IgE-binding determinant of the major allergen Myr p I from the venom of the Australian jumper ant Myrmecia pilosula.
Donovan GR; Street MD; Baldo BA; Alewood D; Alewood P; Sutherland S
Biochim Biophys Acta; 1994 Jan; 1204(1):48-52. PubMed ID: 7508264
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence.
Street MD; Donovan GR; Baldo BA
Biochim Biophys Acta; 1996 Feb; 1305(1-2):87-97. PubMed ID: 8605256
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of pilosulin 1, a peptide from the venom of the jumper ant Myrmecia pilosula.
Wu QX; King MA; Donovan GR; Alewood D; Alewood P; Sawyer WH; Baldo BA
Biochim Biophys Acta; 1998 Sep; 1425(1):74-80. PubMed ID: 9813247
[TBL] [Abstract][Full Text] [Related]
14. Expression of jumper ant (Myrmecia pilosula) venom allergens: post-translational processing of allergen gene products.
Donovan GR; Street MD; Tetaz T; Smith AI; Alewood D; Alewood P; Sutherland SK; Baldo BA
Biochem Mol Biol Int; 1996 Aug; 39(5):877-85. PubMed ID: 8866004
[TBL] [Abstract][Full Text] [Related]
15. Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin.
Zelezetsky I; Pag U; Antcheva N; Sahl HG; Tossi A
Arch Biochem Biophys; 2005 Feb; 434(2):358-64. PubMed ID: 15639237
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of a major allergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula.
Donovan GR; Baldo BA; Sutherland S
Biochim Biophys Acta; 1993 Jan; 1171(3):272-80. PubMed ID: 7678752
[TBL] [Abstract][Full Text] [Related]
17. Separation of jumper ant (Myrmecia pilosula) venom allergens: a novel group of highly basic proteins.
Donovan GR; Street MD; Baldo BA
Electrophoresis; 1995 May; 16(5):804-10. PubMed ID: 7588566
[TBL] [Abstract][Full Text] [Related]
18. Mass Spectrometry Analysis and Biological Characterization of the Predatory Ant Odontomachus monticola Venom and Venom Sac Components.
Tani N; Kazuma K; Ohtsuka Y; Shigeri Y; Masuko K; Konno K; Inagaki H
Toxins (Basel); 2019 Jan; 11(1):. PubMed ID: 30658410
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cell killing by the jumper ant venom peptide pilosulin 1.
King MA; Wu QX; Donovan GR; Baldo BA
Cytometry; 1998 Aug; 32(4):268-73. PubMed ID: 9701394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
